LeafNLP Demos
Back to explore

Report #2867153

Received Nov 13, 2025

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
18 yrs
State
IN
Recovered
Unknown
Vaccinated
Oct 6, 2025
Onset
—
Days to onset
—
Hospital days
—

Vaccines (4)

TypeNameManufacturerDoseLotRoute / Site
HEPAHEP A (VAQTA)MERCK & CO. INC.2Y008483IM / RA
MENBMENINGOCOCCAL B (TRUMENBA)PFIZER\WYETH1HP9988IM / RA
VARCELVARICELLA (VARIVAX)MERCK & CO. INC.1Y011020SC / LA
VARCELVARICELLA (VARIVAX)MERCK & CO. INC.UNKY011020OT

Symptoms (4)

Exposure during pregnancyNo adverse eventProduct use issueContraindication to vaccination

Symptom narrative

Nurse reported that a pregnant patient received a dose of VARIVAX. /"26 weeks pregnant when the dose was given; No additional AE/No PQC reported.; This spontaneous prospective pregnancy report was received from a registered nurse and refers to an 18-year-old female patient. The patient had no pertinent medical history, drug reactions/allergies and concomitant therapies. On 06-Oct-2025, the pregnant patient was vaccinated with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) (lot #Y011020, expiration date: 18-Jun-2026, 1 dose totally, strength unknown), administered by subcutaneous route for immigration vaccination (Maternal exposure during pregnancy). The vaccine was reconstituted with sterile diluent (Hollister-Stier STERILE DILUENT) (lot # and expiration date were not reported). It was reported that the patient was 26 weeks pregnant when the dose was given. No additional adverse event/ No product quality complaints reported. On 07-Apr-2025, the patient became pregnant with the date of last menstrual period of 24-Mar-2025. The pregnancy due date was estimated as 12-Jan-2026. This pregnancy involved 1 fetus(es).

Other medications

Sterile Diluen